Agenda
|
7:30 a.m. |
Registration/Continental Breakfast |
8:30 a.m. |
Opening Remarks
Milton Hernández, Ph.D.
Director, OSPRT
Bethesda, MD |
8:40 a.m. |
Welcome
Anthony S. Fauci, M.D.
Director, NIAID
Bethesda, MD |
8:50 a.m. |
Cultural
Issues in the Retention of Minority Populations
in Clinical Trials
Neil Powe, M.D., M.P.H., M.B.A.
Professor, Johns Hopkins Medical Institutions
Director, Welch Center for Prevention,
Epidemiology, and Clinical Research
Baltimore, MD |
9:30 a.m. |
Refreshment Break |
9:45-11:00 a.m. |
Panel Discussion
Moderator:
Jane Delgado, Ph.D., M.S.
President and Chief Executive Officer
National Alliance for Hispanic Health
Washington, DC
Panelists:
Victoria A. Cargill, M.D., M.S.C.E.
Director of Minority Research, Director
of Clinical Studies
Office of AIDS Research, NIH
Bethesda, MD
Jaquelyn Fleckenstein, M.D.
Associate Professor of Medicine
University of Tennessee Memphis
Memphis, TN
Donna Mildvan, M.D.
Chief, Division of Infectious Diseases
and Principal Investigator
AIDS Clinical Trials Unit, Beth Israel
Medical Center
New York, NY
Herman E. Mitchell, Ph.D.
Senior Research Scientist, Rho Federal
Systems Division, Inc.
Chapel Hill, NC |
11:15 a.m. |
Concurrent
Breakout Sessions
Session 1 - After the Clinical
Trial - Then What?
Discussion Leaders:
Marian C. Limacher, M.D.
Professor of Medicine
University of Florida College of Medicine
Gainesville, FL
Deneen Robinson, B.S.W.
HIV Treatment Consultant
Dallas, TX
Session 2 - Minority Investigators
in Clinical Trials - How Important Are
They?
Discussion Leaders:
Clemente Diaz, M.D.
Professor and Chairman, Department of
Pediatrics
University of Puerto Rico
San Juan, Puerto Rico
Michele K. Evans, M.D.
Deputy Scientific Director, Intramural
Research Program
National Institute on Aging, NIH
Baltimore, MD
Session 3 - Role of the Community
Advisory Board and Outreach Activities
Discussion Leaders:
Anne Madey, B.S., R.N.
Research Nurse Coordinator
University of Tennessee Health Science Center
Memphis, TN
Matthew Murguiá
Director, Office of Program Operations
and Scientific Information
Division of AIDS
NIAID, NIH
Bethesda, MD |
12:30-1:30 p.m. |
Lunch Break |
1:45 p.m. |
Clinical
Trials Resources
Wilma Templin-Branner, M.S.
Oak Ridge Institute for Science and Education
Oak Ridge, TN |
2:15 p.m. |
Why
Primary Care Physicians Don't Refer Their
Patients
John Hogan, M.D.
Medical Officer
Unity Health Care, Inc.
Washington, DC |
3:15 p.m. |
Refreshment Break |
3:30 p.m. |
Recruitment
and Retention: What Works and Why?
Kathleen B. Drennan
Chief, Global Marketing and Strategic
Business Development
Iris Global Clinical Trials Solutions
Chicago, IL
Donald P. Orr, M.D.
Professor of Pediatrics, Nursing Research,
and Dietetics and Nutrition
Director of Adolescent Medicine
Indiana University School of Medicine
Indianapolis, IN |
4:30 p.m. |
Concurrent
Session Reports
Session I: After the Clinical
Trial - Then What?
Marian C. Limacher and Deneen Robinson
Session II: Minority Investigators
in Clinical Trials - How Important Are They?
Clemente Diaz and Michele K. Evans
Session III: Role of the Community
Advisory Board and Outreach Activities
Anne Madey and Matthew Murguia |
4:45 p.m. |
Closing
Remarks/Questions and Answers
Milton Hernández, Ph.D.
Director, OSPRT
Bethesda, MD |
|
|